The Future of Life Sciences, Clinical Research & Healthcare Investment with Steven Meehan & Dr. Ya-El Mandel

Steven Meehan, Managing Director of Scale Life Sciences and Dr. Ya-El Mandel, Senior Vice President of Clinical Operations at Équilibre Biopharmaceuticals Corp., and the founder and CEO of Cardea Sciences, sit down to discuss the future of life sciences, clinical research, and healthcare investment. With a background in investment banking, clinical trials, and biotechnology operations, Steven shares insights into biotech funding trends, AI in life sciences, and private equity investment strategies in healthcare innovation.

The discussion takes a holistic approach to how the political and economic landscape impacts clinical research, why provider groups should enter the clinical trial space, and how private equity investors can optimize their life sciences investments.

Timestamps:

[00:00] Introduction to the podcast and guests, Steven Meehan & Dr. Ya-El Mandel[02:00] Steven’s background: From Wall Street to biotech investments and life sciences strategy[05:30] How private equity in healthcare is adapting to economic and political shifts[08:15] The impact of AI in healthcare and its role in clinical research & biotech advancements[11:00] The challenge of securing funding for small to mid-sized biotech firms[14:30] Why clinical trials are struggling with patient diversity and site participation[18:00] The opportunities for healthcare providers to integrate clinical research infrastructure[21:00] Final thoughts: The future of healthcare leadership, biotech investments, and AI in healthcare

Key Takeaways:

Private equity in healthcare is shifting toward strategic biotech investments. Investors are focusing on scalability, clinical research efficiency, and healthcare innovations.AI in healthcare is a transformative force. AI-driven healthcare trends are improving diagnostic accuracy, patient engagement, and operational efficiency.Diversity in clinical research is critical. Expanding patient recruitment beyond major institutions is essential for better healthcare industry insights and improved treatment outcomes.Healthcare leadership must integrate clinical research. Life sciences advancements depend on stronger partnerships between healthcare providers and biotech firms.

About the Guests:

Steven Meehan is an expert in biotech investments, private equity in healthcare, and life sciences advisory, with a background in investment banking and clinical research strategy.Dr. Ya-El Mandel specializes in clinical trial design, regulatory strategy, and healthcare innovations. She helps healthcare leadership and private equity navigate the complexities of clinical research.

Resources:

Scale Life Sciences Website

Steven Meehan

Website: steven.meehan@moelis.com 

Steven’s Profilelinkedin.com/in/steven-meehan-776530

Dr. Ya-El Mandel 

Website: cardeasciences.com 

Linkedin: https://www.linkedin.com/in/yaelmp/overlay/contact-info/

Steven Meehan is a seasoned professional with over 25 years of expertise in financial and operational leadership, excelling in corporate strategy, mergers and acquisitions, capital raising, and financial planning and analysis. His extensive background demonstrates a strong focus on navigating organizations through complex financial and strategic challenges, with a keen emphasis on value creation and growth acceleration.

Ya-El Mandel, PhD, MSc, is a distinguished leader in biopharmaceuticals and medical innovation. As a founding member and Senior Vice President of Clinical Operations at Équilibre Biopharmaceuticals Corp., and the founder and CEO of Cardea Sciences, she spearheads advancements in non-invasive platforms for Atrial Fibrillation risk assessment. A PhD alumna of the Icahn School of Medicine at Mount Sinai, she also contributes as an adjunct professor. With over a decade of expertise in clinical trials and emergency medical leadership, Dr. Mandel’s work seamlessly integrates academia, industry, and healthcare innovation, driving transformative progress in the field.

: Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Healthcare Innovations, Healthcare Industry Insights, Life Sciences, Clinical Research, AI in Healthcare, Private Equity in Healthcare, Biotech Investment, Steven Meehan, Scale Life Sciences, Dr. Ya-El Mandel, Équilibre Biopharmaceuticals Corp, Cardea Sciences,